Efficient degradation of doxycycline and ofloxacin in an aqueous environment using Fe and Cu doped TiO2-SiO2 photocatalyst under sunlight

Several drugs have sparked interest as potential COVID-19 treatment options. Doxycycline (DOX) has been widely used with other potential agents to reduce COVID-19-induced inflammation. DOX and OFLX, both well-known antimicrobial and anti-inflammatory drugs, were chosen as model pollutants. Fe, Cu-codoped TiO2-SiO2 was synthesised as a novel photocatalyst active under sunlight irradiation to treat model pollutants. The synthesised catalyst samples were meticulously characterised using various techniques to evaluate their morphological, optical, and structural properties. The results of BET analysis showed that the TSFC1 sample has a large specific surface area of 288 m(2)g(-1). Maximum degradation of DOX and OFLX (about 98%) was achieved with the TSFC1 catalyst. The photocatalytic reusability was investigated for up to seven successive cycles, and the composite particles maintained their high photodegradation activity for DOX and OFLX. TFSC1 composite, in particular, demonstrated high catalytic activity as well as excellent recovery potential, and its combination with solar light, silica, and dopants can be introduced as a promising strategy for efficiently destroying both DOX and OFLX antibiotics. This study highlights the feasibility of hybridising doped dual semiconductor nanostructures in implementing solar light-powered pharmaceutical wastewater degradation.

Automated summary

A novel photocatalyst for degrading antibiotics through photocatalysis under sunlight irradiation has been studied. The catalyst showed high activity and maintained it after multiple cycles of use. This study demonstrates the feasibility of hybridizing doped dual semiconductor nanostructures in solar light-powered pharmaceutical wastewater degradation.